Pds Biotechnology Corporation (PDSB)

May 16, 2025

PDS Biotech outlines continued VERSATILE 003 Phase 3 expansion while advancing HPV16-positive head and neck cancer strategy - MSN

May 16, 2025

May 15, 2025

PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025

May 15, 2025

Raymond James Financial Inc. Takes $26,000 Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 15, 2025

May 15, 2025

PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

May 15, 2025

May 15, 2025

PDS Biotechnology Reports Q1 2025 Progress and Financials - TipRanks

May 15, 2025

May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials By Investing.com - Investing.com Nigeria

May 14, 2025

May 14, 2025

PDS Biotechnology: Q1 Earnings Snapshot - Midland Daily News

May 14, 2025

May 14, 2025

EMV Capital portfolio company PDS Biotech advances cancer trial - Proactive Investors

May 14, 2025

May 14, 2025

PDS Biotech advances Phase 3 trial, reports Q1 financials - Investing.com

May 14, 2025

May 14, 2025

Earnings call transcript: PDS Biotech’s Q1 2025 results show reduced losses - Investing.com

May 14, 2025

May 14, 2025

Transcript : PDS Biotechnology Corporation, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025

May 14, 2025

PDSB Advances with Phase 3 Trial for Versamune HPV Therapy | PDS - GuruFocus

May 14, 2025

May 14, 2025

PDS Biotechnology Corporation Initiates VERSATILE-003 Phase 3 Trial and Announces Abstracts Selected for ASCO 2025 - Nasdaq

May 14, 2025

May 14, 2025

PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025

May 14, 2025

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update - TradingView

May 14, 2025

May 13, 2025

PDS Biotechnology (PDSB) Expected to Announce Earnings on Wednesday - Defense World

May 13, 2025

May 09, 2025

Pds Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 09, 2025

May 09, 2025

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - manilatimes.net

May 09, 2025

May 08, 2025

PDS Biotechnology Unveils Promising Flu Vaccine Data - TipRanks

May 08, 2025

May 08, 2025

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting - The Manila Times

May 08, 2025

May 07, 2025

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results - TradingView

May 07, 2025

May 07, 2025

Marshall Wace LLP Has $64,000 Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 07, 2025

May 07, 2025

Renaissance Technologies LLC Acquires 76,800 Shares of PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

May 07, 2025

May 06, 2025

THE CANADIAN INTERNATIONAL TRADE TRIBUNAL TERMINATES ITS PRELIMINARY INJURY INQUIRY IN RESPECT OF TIDEWATER RENEWABLES LTD.'S COUNTERVAILING (ANTI-SUBSIDY) AND ANTI-DUMPING DUTY COMPLAINT RELATING TO I - The Globe and Mail

May 06, 2025

May 04, 2025

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2024 Earnings Call Transcript - MSN

May 04, 2025

May 02, 2025

PDS Biotechnology Enters $20M Securities Purchase Agreement - TipRanks

May 02, 2025

Apr 25, 2025

B. Riley Adjusts Price Target on PDS Biotechnology to $5 From $7, Maintains Buy Rating - marketscreener.com

Apr 25, 2025

Apr 25, 2025

B. Riley Expects Stronger Earnings for PDS Biotechnology - Defense World

Apr 25, 2025

Apr 24, 2025

PDS Biotechnology Director Sir Richard Sykes Retires - TipRanks

Apr 24, 2025

Apr 23, 2025

PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Apr 23, 2025

Apr 23, 2025

PDS Biotechnology Corporation Announces Three Abstracts Accepted for ASCO 2025 on Versamune® HPV Immunotherapy - Nasdaq

Apr 23, 2025

Apr 16, 2025

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting - The Manila Times

Apr 16, 2025

Apr 14, 2025

Raymond James Financial Inc. Takes Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Apr 14, 2025

Apr 08, 2025

Pds Biotech Announces Pds01adc Clinical Data To Be Presented At The American Association For Cancer Research - MarketScreener

Apr 08, 2025

Apr 08, 2025

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Globe and Mail

Apr 08, 2025

Apr 06, 2025

Blair William & Co. IL Purchases 35,757 Shares of PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Apr 06, 2025

Apr 04, 2025

3 Reasons to Avoid GAP and 1 Stock to Buy Instead - The Globe and Mail

Apr 04, 2025

Apr 01, 2025

PDSB stock touches 52-week low at $1.12 amid market challenges - Investing.com

Apr 01, 2025

Mar 31, 2025

Virtu Financial LLC Takes $89,000 Position in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Mar 31, 2025

Mar 31, 2025

PDS Biotechnology Stock In Spotlight On Better-Than-Feared 2024 Loss – Retail Stays Bearish - Asianet Newsable

Mar 31, 2025

Mar 29, 2025

HC Wainwright Has Lowered Expectations for PDS Biotechnology (NASDAQ:PDSB) Stock Price - Defense World

Mar 29, 2025

Mar 28, 2025

H.C. Wainwright cuts PDS Biotechnology stock target to $13 By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

H.C. Wainwright cuts PDS Biotechnology stock target to $13 - Investing.com India

Mar 28, 2025

Mar 28, 2025

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Mar 28, 2025

Mar 28, 2025

PDS Biotechnology Advances Cancer Immunotherapy Trials - TipRanks

Mar 28, 2025

Mar 27, 2025

Earnings call transcript: PDS Biotech Q4 2024 shows narrowed loss, stock rises By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

PDS Biotech commences phase 3 trial for HPV cancer therapy By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

PDS Biotech commences phase 3 trial for HPV cancer therapy - Investing.com

Mar 27, 2025